Pujol JL - Search Results

1

Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.

Bousquet Mur E, Bernardo S, Papon L, Mancini M, Fabbrizio E, Goussard M, Ferrer I, Giry A, Quantin X, Pujol JL, Calvayrac O, Moll HP, Glasson Y, Pirot N, Turtoi A, Cañamero M, Wong KK, Yarden Y, Casanova E, Soria JC, Colinge J, Siebel CW, Mazieres J, Favre G, Paz-Ares L, Maraver A. Bousquet Mur E, et al. Among authors: pujol jl. J Clin Invest. 2020 Feb 3;130(2):612-624. doi: 10.1172/JCI126896. J Clin Invest. 2020. PMID: 31671073 Free PMC article.

2

Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.

Pujol JL, Grenier J, Parrat E, Lehmann M, Lafontaine T, Quantin X, Michel FB. Pujol JL, et al. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):725-33. doi: 10.1164/ajrccm.154.3.8810612. Am J Respir Crit Care Med. 1996. PMID: 8810612

3

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.

Pujol JL, Simony J, Jolimoy G, Jaffuel D, Demoly P, Quantin X, Marty-Ané C, Boher JM, Charpentier R, Michel FB. Pujol JL, et al. Br J Cancer. 1996 Sep;74(6):964-70. doi: 10.1038/bjc.1996.466. Br J Cancer. 1996. PMID: 8826867 Free PMC article.

4

[Cellular growth factors in the treatment of bronchogenic cancers].

Pujol JL, Quantin X, Michel FB. Pujol JL, et al. Rev Mal Respir. 1996;13(4):335-8. Rev Mal Respir. 1996. PMID: 8927788 Review. French. No abstract available.

5

Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer.

Quantin X, Pujol JL, Lehmann M, Simony J, Serre I, Michel FB. Quantin X, et al. Among authors: pujol jl. Cancer Detect Prev. 1997;21(5):418-25. Cancer Detect Prev. 1997. PMID: 9307845

6

Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer.

Quantin X, Pujol JL, Paris A, Reme-Saumon M, Khial F, Godard P, Michel FB. Quantin X, et al. Among authors: pujol jl. Ann Oncol. 1997 Sep;8(9):911-3. doi: 10.1023/a:1008217731021. Ann Oncol. 1997. PMID: 9358944 Free article.

7

Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy.

Ray P, Quantin X, Grenìer J, Pujol JL. Ray P, et al. Among authors: pujol jl. Cancer Detect Prev. 1998;22(4):293-304. doi: 10.1046/j.1525-1500.1998.cdoa43.x. Cancer Detect Prev. 1998. PMID: 9674872

8

[Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model].

Pujol JL, Boher JM, Grenier J, Quantin X, Saffont L, Daurès JP. Pujol JL, et al. Rev Mal Respir. 1998 Sep;15(4):519-25. Rev Mal Respir. 1998. PMID: 9805763 French.

9

[New cytotoxics in the treatment of bronchial cancers].

Quantin X, Godard P, Michel FB, Pujol JL. Quantin X, et al. Among authors: pujol jl. Rev Mal Respir. 1998 Oct;15(5):597-612. Rev Mal Respir. 1998. PMID: 9834987 Review. French.

10

Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.

Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB. Pujol JL, et al. Chest. 1999 Jan;115(1):144-50. doi: 10.1378/chest.115.1.144. Chest. 1999. PMID: 9925076 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters